Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty.
about
Contemporary issues in precocious pubertyUrinary metabolite markers of precocious pubertyCurrent pharmacotherapy of central precocious puberty by GnRH analogs: certainties and uncertainties.Overnight luteinizing and follicle stimulating hormone profiles during GnRHa treatment in short girls born small for gestational age.Avanços na etiologia, no diagnóstico e no tratamento da puberdade precoce centralCentral precocious puberty: treatment with triptorelin 11.25 mg
P2860
Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Three-month sustained-release ...... of central precocious puberty.
@en
Three-month sustained-release triptorelin
@nl
type
label
Three-month sustained-release ...... of central precocious puberty.
@en
Three-month sustained-release triptorelin
@nl
prefLabel
Three-month sustained-release ...... of central precocious puberty.
@en
Three-month sustained-release triptorelin
@nl
P2093
P356
P1476
Three-month sustained-release ...... of central precocious puberty.
@en
P2093
Catherine Adamsbaum
Christine Seymour
Jean-Claude Carel
Joëlle Blumberg
Najiba Lahlou
Triptorelin 3-month CPP Study Group
P304
P356
10.1530/EJE.1.02056
P577
2006-01-01T00:00:00Z